Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date | Activity Code(s) Sort descending | Title |
|---|---|---|---|
| PAR-23-199 | May 26, 2025 | U24 | ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed) |
| RFA-NS-22-011 | October 12, 2024 | U24 | BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) |
| RFA-MH-25-105 | July 2, 2026 | U24 | BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed) |
| RFA-NS-23-026 | October 12, 2024 | U24 | BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) |
| NOT-OD-24-058 | January 8, 2027 | U24,R01,R21,R34,UG3/UH3,R03 | Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being |
| PAR-24-063 | August 19, 2026 | U44 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
| PAR-21-282 | June 21, 2024 | U44 | Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) |
| NOT-NS-23-002 | June 21, 2024 | U44,UG3/UH3 | Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech |
| NOT-NS-22-052 | June 21, 2024 | U44,UG3/UH3 | Notice of Special Interest (NOSI): BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech |
| PAR-24-206 | August 14, 2024 | U54 | Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) |
| RFA-AG-25-002 | July 3, 2024 | U54 | Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional) |
| RFA-NS-24-016 | January 29, 2027 | UG3/UH3 | BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
| RFA-MH-22-115 | June 8, 2024 | UG3/UH3 | BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) |
| RFA-MH-23-295 | June 8, 2024 | UG3/UH3 | BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) |
| PAR-22-167 | October 18, 2024 | UG3/UH3 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) |
| PAR-21-315 | June 21, 2024 | UG3/UH3 | Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) |
| PAR-24-043 | August 19, 2026 | UG3/UH3 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
| RFA-NS-24-019 | January 8, 2027 | UG3/UH3 | HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) |
| PAR-21-163 | May 8, 2024 | UG3/UH3 | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
| RFA-NS-24-017 | January 29, 2027 | UH3 | BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) |
BACK TO TOP